AddLife acquires and streamlines profitable market-leading niche companies in the field of Life Science. We will attain long-term profitable growth by continuously developing our business and organisation. AddLife combines the strength of a large enterprise with the dedication and business skills of an entrepreneur.
When quick decisions are required, such as during the COVID-19 pandemic, simplicity is important. In collaboration with our suppliers, we developed new purchasing processes and set up delivery plans in an extremely short time so that our customers could perform COVID-19 tests. Simplicity permeates everything we do and streamlines our work.
AddLife owns and develops companies that enhance quality of life, reduce patient suffering and increase social benefit. To achieve this vision, we offer our subsidiaries competitive solutions that meet both the short-term and long-term needs of the customers. Below is our assessment of why AddLife has become a leading, value-generating operator in Life Science.